Modern Biosciences plc appoints Dr Clive Dix as Non-Executive Chairman
Clive, aged 52, was previously the Chief Executive Officer of PowderMed Ltd, the Oxford-based vaccines company. In 2004, he led the spin-out of PowderMed from Chiron Vaccines, a business unit of Chiron Corporation, backed by £20 million in venture capital from a syndicate of leading life science investors. Clive oversaw the sale of PowderMed to Pfizer Inc in October 2006.
Prior to running PowderMed, Clive was Senior Vice President, Research and Development and a Board member of PowderJect Pharmaceuticals plc, a vaccines company that was acquired by Chiron for £550 million in 2003. Clive worked at PowderJect and Chiron from 2001 until 2004 and was previously Glaxo Wellcome's UK Research Director where his role included co-chairing the management group that oversaw all of the company's research projects worldwide.
Clive has more than 22 years' experience in the pharmaceutical and biotechnology industries, encompassing business leadership, project management and drug development.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.